Richard William Scalzo, SVP, Head of Finance & Administration at Dyne Therapeutics, Inc. (DYN), sold 174,887 shares at $26.72 ($4.6M) on 2024-03-08, disclosed to the SEC on 2024-03-12.
Scheduled sale ($4.6M) by SVP, Head of Finance & Administration under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.31 | 30,755 | $778K | 17.0% |
| 2 | $25.31 | 30,755 | $778K | 17.0% |
| 3 | $26.72 | 55,208 | $1.5M | 32.2% |
| 4 | $26.72 | 55,208 | $1.5M | 32.2% |
| 5 | $27.33 | 289 | $8K | 0.2% |
| 6 | $24.99 | 1,590 |
| $40K |
| 0.9% |
| 7 | $25.70 | 1,082 | $28K | 0.6% |
| Total | $26.20 avg | 174,887 | $4.6M | 100% |
| Filing → |
| DYN | SELL | 2025-03-13 | $15K | — | Filing → |
| DYN | SELL | 2025-03-07 | $11K | — | Filing → |
| DYN | SELL | 2025-02-18 | $35K | — | Filing → |